List of Tables
Table 1. Global Human Coronavirus Nucleoprotein Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Human Coronavirus Nucleoprotein Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Human Coronavirus Nucleoprotein Market Competitive Situation by Manufacturers in 2024
Table 4. Global Human Coronavirus Nucleoprotein Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Human Coronavirus Nucleoprotein Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Human Coronavirus Nucleoprotein Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Human Coronavirus Nucleoprotein Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Human Coronavirus Nucleoprotein Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Human Coronavirus Nucleoprotein, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Human Coronavirus Nucleoprotein, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Coronavirus Nucleoprotein, Product Type & Application
Table 12. Global Key Manufacturers of Human Coronavirus Nucleoprotein, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Coronavirus Nucleoprotein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coronavirus Nucleoprotein as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Coronavirus Nucleoprotein Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Human Coronavirus Nucleoprotein Sales by Region (2020-2025) & (K Units)
Table 18. Global Human Coronavirus Nucleoprotein Sales Market Share by Region (2020-2025)
Table 19. Global Human Coronavirus Nucleoprotein Sales by Region (2026-2031) & (K Units)
Table 20. Global Human Coronavirus Nucleoprotein Sales Market Share by Region (2026-2031)
Table 21. Global Human Coronavirus Nucleoprotein Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Human Coronavirus Nucleoprotein Revenue Market Share by Region (2020-2025)
Table 23. Global Human Coronavirus Nucleoprotein Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Human Coronavirus Nucleoprotein Revenue Market Share by Region (2026-2031)
Table 25. North America Human Coronavirus Nucleoprotein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Human Coronavirus Nucleoprotein Sales by Country (2020-2025) & (K Units)
Table 27. North America Human Coronavirus Nucleoprotein Sales by Country (2026-2031) & (K Units)
Table 28. North America Human Coronavirus Nucleoprotein Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Human Coronavirus Nucleoprotein Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Human Coronavirus Nucleoprotein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Human Coronavirus Nucleoprotein Sales by Country (2020-2025) & (K Units)
Table 32. Europe Human Coronavirus Nucleoprotein Sales by Country (2026-2031) & (K Units)
Table 33. Europe Human Coronavirus Nucleoprotein Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Human Coronavirus Nucleoprotein Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Human Coronavirus Nucleoprotein Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Human Coronavirus Nucleoprotein Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Human Coronavirus Nucleoprotein Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Human Coronavirus Nucleoprotein Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Human Coronavirus Nucleoprotein Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human Coronavirus Nucleoprotein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Human Coronavirus Nucleoprotein Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Human Coronavirus Nucleoprotein Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Human Coronavirus Nucleoprotein Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Human Coronavirus Nucleoprotein Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Human Coronavirus Nucleoprotein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Human Coronavirus Nucleoprotein Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Human Coronavirus Nucleoprotein Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Human Coronavirus Nucleoprotein Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Human Coronavirus Nucleoprotein Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Human Coronavirus Nucleoprotein Sales (K Units) by Type (2020-2025)
Table 51. Global Human Coronavirus Nucleoprotein Sales (K Units) by Type (2026-2031)
Table 52. Global Human Coronavirus Nucleoprotein Sales Market Share by Type (2020-2025)
Table 53. Global Human Coronavirus Nucleoprotein Sales Market Share by Type (2026-2031)
Table 54. Global Human Coronavirus Nucleoprotein Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Human Coronavirus Nucleoprotein Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Human Coronavirus Nucleoprotein Revenue Market Share by Type (2020-2025)
Table 57. Global Human Coronavirus Nucleoprotein Revenue Market Share by Type (2026-2031)
Table 58. Global Human Coronavirus Nucleoprotein Price (US$/Unit) by Type (2020-2025)
Table 59. Global Human Coronavirus Nucleoprotein Price (US$/Unit) by Type (2026-2031)
Table 60. Global Human Coronavirus Nucleoprotein Sales (K Units) by Application (2020-2025)
Table 61. Global Human Coronavirus Nucleoprotein Sales (K Units) by Application (2026-2031)
Table 62. Global Human Coronavirus Nucleoprotein Sales Market Share by Application (2020-2025)
Table 63. Global Human Coronavirus Nucleoprotein Sales Market Share by Application (2026-2031)
Table 64. Global Human Coronavirus Nucleoprotein Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Human Coronavirus Nucleoprotein Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Human Coronavirus Nucleoprotein Revenue Market Share by Application (2020-2025)
Table 67. Global Human Coronavirus Nucleoprotein Revenue Market Share by Application (2026-2031)
Table 68. Global Human Coronavirus Nucleoprotein Price (US$/Unit) by Application (2020-2025)
Table 69. Global Human Coronavirus Nucleoprotein Price (US$/Unit) by Application (2026-2031)
Table 70. Abcam Company Information
Table 71. Abcam Description and Business Overview
Table 72. Abcam Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Abcam Human Coronavirus Nucleoprotein Product
Table 74. Abcam Recent Developments/Updates
Table 75. The Native Antigen Company Company Information
Table 76. The Native Antigen Company Description and Business Overview
Table 77. The Native Antigen Company Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. The Native Antigen Company Human Coronavirus Nucleoprotein Product
Table 79. The Native Antigen Company Recent Developments/Updates
Table 80. Bio-Rad Laboratories Company Information
Table 81. Bio-Rad Laboratories Description and Business Overview
Table 82. Bio-Rad Laboratories Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Bio-Rad Laboratories Human Coronavirus Nucleoprotein Product
Table 84. Bio-Rad Laboratories Recent Developments/Updates
Table 85. Thermo Fisher Scientific Company Information
Table 86. Thermo Fisher Scientific Description and Business Overview
Table 87. Thermo Fisher Scientific Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Thermo Fisher Scientific Human Coronavirus Nucleoprotein Product
Table 89. Thermo Fisher Scientific Recent Developments/Updates
Table 90. Agrisera Company Information
Table 91. Agrisera Description and Business Overview
Table 92. Agrisera Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Agrisera Human Coronavirus Nucleoprotein Product
Table 94. Agrisera Recent Developments/Updates
Table 95. Merck KGaA (Sigma-Aldrich) Company Information
Table 96. Merck KGaA (Sigma-Aldrich) Description and Business Overview
Table 97. Merck KGaA (Sigma-Aldrich) Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Merck KGaA (Sigma-Aldrich) Human Coronavirus Nucleoprotein Product
Table 99. Merck KGaA (Sigma-Aldrich) Recent Developments/Updates
Table 100. Seebio Company Information
Table 101. Seebio Description and Business Overview
Table 102. Seebio Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Seebio Human Coronavirus Nucleoprotein Product
Table 104. Seebio Recent Developments/Updates
Table 105. Elabscience Company Information
Table 106. Elabscience Description and Business Overview
Table 107. Elabscience Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Elabscience Human Coronavirus Nucleoprotein Product
Table 109. Elabscience Recent Developments/Updates
Table 110. Novus Biologicals Company Information
Table 111. Novus Biologicals Description and Business Overview
Table 112. Novus Biologicals Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Novus Biologicals Human Coronavirus Nucleoprotein Product
Table 114. Novus Biologicals Recent Developments/Updates
Table 115. Sinobiological Company Information
Table 116. Sinobiological Description and Business Overview
Table 117. Sinobiological Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Sinobiological Human Coronavirus Nucleoprotein Product
Table 119. Sinobiological Recent Developments/Updates
Table 120. Eagle Biosciences Company Information
Table 121. Eagle Biosciences Description and Business Overview
Table 122. Eagle Biosciences Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Eagle Biosciences Human Coronavirus Nucleoprotein Product
Table 124. Eagle Biosciences Recent Developments/Updates
Table 125. BiosPacific Company Information
Table 126. BiosPacific Description and Business Overview
Table 127. BiosPacific Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. BiosPacific Human Coronavirus Nucleoprotein Product
Table 129. BiosPacific Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Human Coronavirus Nucleoprotein Distributors List
Table 133. Human Coronavirus Nucleoprotein Customers List
Table 134. Human Coronavirus Nucleoprotein Market Trends
Table 135. Human Coronavirus Nucleoprotein Market Drivers
Table 136. Human Coronavirus Nucleoprotein Market Challenges
Table 137. Human Coronavirus Nucleoprotein Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Human Coronavirus Nucleoprotein
Figure 2. Global Human Coronavirus Nucleoprotein Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human Coronavirus Nucleoprotein Market Share by Type: 2024 & 2031
Figure 4. 90%≤Purity≤95% Product Picture
Figure 5. Purity＞95% Product Picture
Figure 6. Other Product Picture
Figure 7. Global Human Coronavirus Nucleoprotein Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Human Coronavirus Nucleoprotein Market Share by Application: 2024 & 2031
Figure 9. RDT & ELISA
Figure 10. Vaccine Development
Figure 11. Antiviral Drugs
Figure 12. Research
Figure 13. Other
Figure 14. Global Human Coronavirus Nucleoprotein Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Human Coronavirus Nucleoprotein Market Size (2020-2031) & (US$ Million)
Figure 16. Global Human Coronavirus Nucleoprotein Sales (2020-2031) & (K Units)
Figure 17. Global Human Coronavirus Nucleoprotein Average Price (US$/Unit) & (2020-2031)
Figure 18. Human Coronavirus Nucleoprotein Report Years Considered
Figure 19. Human Coronavirus Nucleoprotein Sales Share by Manufacturers in 2024
Figure 20. Global Human Coronavirus Nucleoprotein Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Human Coronavirus Nucleoprotein Players: Market Share by Revenue in Human Coronavirus Nucleoprotein in 2024
Figure 22. Human Coronavirus Nucleoprotein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Human Coronavirus Nucleoprotein Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Human Coronavirus Nucleoprotein Sales Market Share by Country (2020-2031)
Figure 25. North America Human Coronavirus Nucleoprotein Revenue Market Share by Country (2020-2031)
Figure 26. United States Human Coronavirus Nucleoprotein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Human Coronavirus Nucleoprotein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Human Coronavirus Nucleoprotein Sales Market Share by Country (2020-2031)
Figure 29. Europe Human Coronavirus Nucleoprotein Revenue Market Share by Country (2020-2031)
Figure 30. Germany Human Coronavirus Nucleoprotein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Human Coronavirus Nucleoprotein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Human Coronavirus Nucleoprotein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Human Coronavirus Nucleoprotein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Human Coronavirus Nucleoprotein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Human Coronavirus Nucleoprotein Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Human Coronavirus Nucleoprotein Revenue Market Share by Region (2020-2031)
Figure 37. China Human Coronavirus Nucleoprotein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Human Coronavirus Nucleoprotein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Human Coronavirus Nucleoprotein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Human Coronavirus Nucleoprotein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Human Coronavirus Nucleoprotein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Human Coronavirus Nucleoprotein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Human Coronavirus Nucleoprotein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Human Coronavirus Nucleoprotein Sales Market Share by Country (2020-2031)
Figure 45. Latin America Human Coronavirus Nucleoprotein Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Human Coronavirus Nucleoprotein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Human Coronavirus Nucleoprotein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Human Coronavirus Nucleoprotein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Human Coronavirus Nucleoprotein Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Human Coronavirus Nucleoprotein Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Human Coronavirus Nucleoprotein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Human Coronavirus Nucleoprotein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Human Coronavirus Nucleoprotein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Human Coronavirus Nucleoprotein by Type (2020-2031)
Figure 55. Global Revenue Market Share of Human Coronavirus Nucleoprotein by Type (2020-2031)
Figure 56. Global Human Coronavirus Nucleoprotein Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Human Coronavirus Nucleoprotein by Application (2020-2031)
Figure 58. Global Revenue Market Share of Human Coronavirus Nucleoprotein by Application (2020-2031)
Figure 59. Global Human Coronavirus Nucleoprotein Price (US$/Unit) by Application (2020-2031)
Figure 60. Human Coronavirus Nucleoprotein Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
